| Hsu BG |
------>authors3_c= ------>paper_class1=1 ------>Impact_Factor=0.623 ------>paper_class3=2 ------>paper_class2=1 ------>vol=29 ------>confirm_bywho=hychiou ------>insert_bywho=liyu ------>Jurnal_Rank=87.3 ------>authors4_c= ------>comm_author= ------>patent_EDate=None ------>authors5_c= ------>publish_day=1 ------>paper_class2Letter=None ------>page2=557 ------>medlineContent= ------>unit=J0200 ------>insert_date=20081127 ------>iam=7 ------>update_date=None ------>author=??? ------>change_event=4 ------>ISSN= ------>authors_c= ------>score=383 ------>journal_name=Renal Failure ------>paper_name=Transfusion-transmitted virus (TTV) infection in patients on peritoneal dialysis in Taiwan ------>confirm_date=20081203 ------>tch_id=097008 ------>pmid=17654317 ------>page1=553 ------>fullAbstract=Many studies have reported the prevalence of transfusion-transmitted virus (TTV) infection in hemodialysis patients, but few reports studied the prevalence of TTV infection in peritoneal dialysis patients. In this study, we determined the prevalence of TTV in a peritoneal dialysis population in Taiwan and related its prevalence with history of blood transfusion, serum hepatitis B surface antigen (HBsAg), antibody to hepatitis C virus (anti-HCV), and serum aminotransferases (AST and ALT) levels. Serum samples from 47 peritoneal dialysis patients and a control group of 43 patients at health examination were studied for TTV viremia by using polymerase chain reaction. The rate of blood transfusion exposure (p < 0.0001), female gender (p = 0.001), younger age (p = 0.0014), and serum AST level (p = 0.012) were significantly higher in peritoneal dialysis patients. The prevalence of TTV viremia was not significantly different between peritoneal dialysis patients and the control group (23.4% vs. 37.2%). TTV infection was not associated with evident liver diseases in peritoneal dialysis patients, and the infection rate was not different between automated peritoneal dialysis (APD) and continuous ambulatory peritoneal dialysis (CAPD) patients. There was no statistically significant association between TTV infection and age, gender, transfusion history, duration of peritoneal dialysis, AST level, ALT level, HBsAg, or anti-HCV seropositivity in peritoneal dialysis patients. Our results suggest that TTV infection is not associated with evident liver diseases, and there is no difference between TTV infection in healthy individuals and peritoneal dialysis patients. TTV transmission probably occurs via routes unrelated to peritoneal dialysis. ------>tmu_sno=None ------>sno=19936 ------>authors2=Lin HH ------>authors3=Hu CT ------>authors4=Wang CH ------>authors5=Fang TC ------>authors6=Wang LY ------>authors6_c= ------>authors=Hsu BG ------>delete_flag=0 ------>SCI_JNo=None ------>authors2_c= ------>publish_area=0 ------>updateTitle=TT virus infection in patients on peritoneal dialysis in Taiwan. ------>language=2 ------>check_flag=None ------>submit_date=None ------>country=None ------>no= ------>patent_SDate=None ------>update_bywho=None ------>publish_year=2007 ------>submit_flag=None ------>publish_month=1 |